Raises NAD but Not Cognition: Clinician Path for NAD+ and Brain Fog

September 29, 2026
Clinical trial samples beside cognitive assessment device

NAD+ does not have reliable, reproducible evidence behind it as a fix for brain fog. Oral precursors like nicotinamide riboside consistently raise blood NAD+ levels, but that biochemical change has not translated into consistent improvements on cognitive tests in controlled trials. Before spending money on NAD+ in any form, it makes sense to rule out common, treatable causes like poor sleep, thyroid problems, low iron, or medication side effects, then talk to a clinician if you still want to try it.

TL;DR:

  • Human trials show that raising blood NAD+ levels through supplementation does not produce consistent improvements in cognitive tests or brain fog symptoms.
  • The increase in NAD+ from various delivery methods like oral precursors or injections has not demonstrated clear benefits for cognition or mental clarity in controlled studies.
  • Short trial durations, narrow study populations, and combined supplement ingredients limit the conclusion that NAD+ effectively treats common brain fog.
  • Safe NAD+ use requires careful sourcing, clinician oversight, and baseline health assessments to avoid risks, especially with injectable or high-dose products.
  • Addressing sleep, thyroid function, nutrient deficiencies, medication effects, and mental health should be prioritized before considering NAD+ as a treatment.
Revive Meds
Explore Clinician-Supervised NAD+ Care
Revive Meds provides clinician-reviewed NAD+ and peptide therapies with tailored support and unlimited provider messaging throughout treatment.

Explore NAD+ care

Table of Contents

What the human evidence says about NAD+ and brain fog

The strongest data on NAD+ and cognition comes from randomized trials, and the pattern is consistent: NAD+ goes up, symptoms mostly do not follow.

A 24-week randomized controlled trial in people with long COVID found that nicotinamide riboside raised blood NAD+ levels substantially, but the increase did not produce significant differences between treatment and placebo groups on cognitive measures, fatigue, sleep quality, or mood. Some exploratory within-group analyses hinted at improvement after 10 weeks, but those signals were not confirmed against placebo, which is the comparison that actually tells you whether a treatment works.

A separate phase-II pilot trial in older adults with mild cognitive impairment tells a similar story. Over 8 to 12 weeks, nicotinamide riboside at 500 to 1,000 milligrams per day increased blood NAD+ and even boosted hippocampal blood flow, yet cognitive test scores did not improve any more than they did with placebo.

A trial over several months found NAD+ levels rose while cognitive scores did not budge relative to placebo, which is the gap that matters most for anyone considering NAD+ specifically for brain fog.

A few things limit how far these results can be pushed:

  • Trial samples have been small, and most run less than 24 weeks, which may be too short to detect a real cognitive effect if one exists.
  • Study populations are narrow (long COVID, mild cognitive impairment), so results may not generalize to everyday, non-disease-related brain fog.
  • Some supplement trials combine NAD+ precursors with other ingredients, making it hard to credit any benefit to NAD+ alone.
  • Animal studies show clearer effects on inflammation and cognition than human trials do, and that gap between species is common in nutrition and metabolic research.

The practical read: raising your NAD+ level is not the same as clearing your head, and no trial to date supports NAD+ as a routine fix for garden-variety brain fog.

How NAD+ therapies are delivered and what that implies

The route NAD+ takes into your body changes what you can honestly expect from it.

  • Oral precursors (NR, NMN): These reliably raise blood NAD+ and make up almost all of the controlled human cognition data available, limited as it is.
  • IV NAD+: Marketed for rapid effects, but the human evidence is largely pharmacokinetic, showing that NAD+ levels rise, not that cognition improves.
  • Nasal sprays: Similar story: appealing for speed and convenience, but without rigorous cognitive trials to back the marketing.
  • Compounded injectable NAD+: Offers more control over dose and timing than oral options, but quality depends entirely on the compounding pharmacy, and sourcing matters more here than with any other route.

None of this means one route is proven better than another for brain fog specifically. It means the delivery method controls how fast NAD+ shows up in your blood, not whether raising it actually clears your thinking. Anyone expecting a fast, dramatic mental lift from an IV drip or a nasal spray is extrapolating well past what the trials have shown.

Safety, dosing ranges, and quality concerns worth knowing

Across the trials, tolerability has generally been reasonable: mild gastrointestinal symptoms were the most common complaints, and serious adverse events were uncommon, though researchers monitored participants closely throughout.

The dose matters more than people expect. Nicotinamide, a form of vitamin B3 related to NAD+ metabolism, can cause gastrointestinal upset, easy bruising, and increased bleeding risk at high intakes, with dose-related liver toxicity a concern at very high levels (according to NIH’s Office of Dietary Supplements), particularly at 3,000 milligrams per day or more.

Compounded injectable products carry a separate set of risks. The FDA has investigated adverse events tied to compounded injectables where the product’s pH or stability caused injection-site harm, and compounded drugs, unlike FDA-approved medications, do not go through premarket review for safety or effectiveness.

Before trying any injectable NAD+ product, work through this checklist:

  1. Ask the pharmacy for a certificate of analysis (COA) for the specific batch.
  2. Confirm the compounder is FDA-registered, not just state-licensed.
  3. Make sure a clinician reviews your history and labs before you start.
  4. Get baseline liver enzyme labs and repeat them if you continue treatment.
  5. Stop and contact your provider if you notice injection-site pain, swelling, or unusual fatigue.

Pro Tip: Ask any provider offering NAD+ injections whether they can show you the compounding pharmacy’s FDA registration status before you agree to treatment.

Who might plausibly benefit, and what to try first

Brain fog rarely has one cause, so the first move is elimination, not supplementation.

  • Get a sleep study or at least tighten sleep hygiene: undiagnosed sleep apnea is a common, fixable driver of mental fog.
  • Check thyroid function (TSH and free T4), since both an underactive and overactive thyroid can blunt focus.
  • Test ferritin and iron studies, plus B12, since deficiencies in either are common and treatable.
  • Review your medication list with a pharmacist or doctor for anything that can cause cognitive slowing.
  • Screen for depression and anxiety, which frequently present as foggy thinking rather than obvious mood symptoms.

If those come back clear, NAD+ becomes a reasonable adjunct to discuss, particularly for people recovering from post-viral illness or with documented metabolic or mitochondrial issues. A sensible approach:

  1. Set a fixed trial period, such as 8 to 12 weeks, matching the duration used in available trials.
  2. Track a specific, measurable outcome (a validated fatigue or cognition scale, not just a vague sense of feeling better).
  3. Reassess with your clinician at the end of the period and stop if there is no measurable change.

A clinician-supervised pathway for considering NAD+

A responsible NAD+ protocol starts with a full medical history, baseline labs, and a clinician who checks for exclusion criteria before anything is prescribed, not after. Sourcing safeguards matter just as much: FDA-registered compounding, certificates of analysis, and purity and sterility checks reduce, though never eliminate, the risks tied to compounded injectables (per the FDA). Ongoing care should include symptom tracking, periodic liver enzyme labs, and a direct line to your provider if side effects appear. NAD+ should be framed from the start as a possible adjunct, never a guaranteed fix, with clear cost and logistics expectations set upfront.

A clinician-supervised pathway for considering NAD+ — overview diagram

Author Amy’s perspective on using NAD+ for brain fog

Be skeptical of any single molecule promising to fix a symptom as multifactorial as brain fog. NAD+ is biologically interesting, but the human data so far is thin, and I would treat it as a last step after sleep, thyroid, iron, and medications have been ruled out, not a first one. If you do try it, do so conservatively, with a clinician tracking the results, and stay open to the fact that larger trials could change this picture in either direction.

— Amy

How Revive Meds can help with clinician-supervised NAD+ care

If you have ruled out the basics and still want to try NAD+, the safest path is one with a clinician involved from intake through follow-up, not a drip clinic that skips the review step. Revive Meds runs every NAD+ protocol through a full medical intake reviewed by a licensed clinician, uses FDA-registered compounding pharmacies with purity testing, and ships discreetly to your door.

Revive Meds

What that looks like in practice:

  • A clinician reviews your history and goals before anything is prescribed.
  • You get access to NAD+ nasal spray, injection, and flex-dose tablet options depending on what fits your situation.
  • Provider messaging is available to communicate about side effects or questions during treatment.
  • There are no membership fees or long-term contracts, just the agreed treatment protocol.

If you want to see current NAD+ options and get matched with a clinician, start with Revive Meds’ wellness offerings.

Sources

These are the primary trial and regulatory sources behind the claims above, useful if you want to read further or bring them to a clinician.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What is the downside of taking NAD?

The main downsides are limited proof of benefit for everyday brain fog and safety concerns tied to high doses or poorly sourced compounded products. High intakes of nicotinamide can cause gastrointestinal upset, bruising, bleeding risk, and liver strain, according to NIH’s dietary supplement guidance.

What is the best vitamin to clear brain fog?

There is no single vitamin proven to reliably clear brain fog, since it usually stems from sleep, thyroid, iron, medication, or mood issues rather than one nutrient gap. Correcting a genuine deficiency, such as low B12 or iron, tends to help more than adding a supplement on top of normal levels.

Is NAD like Adderall?

No. NAD+ works on cellular energy metabolism, while Adderall is a stimulant medication that directly affects brain neurotransmitters and requires a prescription for diagnosed conditions like ADHD. Their mechanisms, regulatory status, and evidence bases are entirely different.

Why do I feel so good on NAD?

Reported improvements after NAD+ may reflect the supervised routine itself (better sleep, hydration, and attention to health) rather than NAD+ specifically, since placebo-controlled trials have not confirmed a consistent cognitive effect. A genuine response is possible for some people, but it has not been reproduced reliably against placebo in controlled research.